Xochitl Castaneda - Mdica Sur Independent Director
| MEDICAB Stock | MXN 33.60 0.20 0.59% |
Director
Dr. Xochitl Castaneda serves as Independent Director at Medica Sur, S.A.B. de C.V since April 11, 2014. She is known as a Professor and Researcher of Instituto Mexicano de Salud Publica. Also, in 1999 she received a national award regarding to her research in social science and medicine. She holds a Doctorate in Philosophy degree in Health from California State University, San Francisco. since 2014.
| Tenure | 11 years |
| Professional Marks | Ph.D |
| Phone | 52 55 4635 5600 |
| Web | https://www.medicasur.com.mx |
Mdica Sur Management Efficiency
The company has return on total asset (ROA) of 0.0682 % which means that it generated a profit of $0.0682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1095 %, meaning that it generated $0.1095 on every $100 dollars invested by stockholders. Mdica Sur's management efficiency ratios could be used to measure how well Mdica Sur manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Tomas Santos | CEMEX SAB de | 54 | |
| Albert Gore | Apple Inc | 71 | |
| Juan Herrera | Axtel SAB de | N/A | |
| Francisco Carbajal | CEMEX SAB de | 64 | |
| David Guzman | CEMEX SAB de | 61 | |
| Armando Sada | Axtel SAB de | 61 | |
| Carlos Ancira | Fomento Econmico Mexicano | 62 | |
| Alberto Boesch | Axtel SAB de | N/A | |
| Michael Larson | Fomento Econmico Mexicano | 59 | |
| Fernando Olivieri | Axtel SAB de | 64 | |
| Robert Denham | Fomento Econmico Mexicano | 73 | |
| Raul Ibarra | Axtel SAB de | N/A | |
| Ricardo Touche | Fomento Econmico Mexicano | 71 | |
| Bernardo Reynoso | Axtel SAB de | N/A | |
| Jose Rojas | Fomento Econmico Mexicano | 64 | |
| Paulino Mendivil | Axtel SAB de | 68 | |
| Alejandro Barragan | Axtel SAB de | N/A | |
| Ramon Chapa | Axtel SAB de | 49 | |
| Francisco Carbajal | Fomento Econmico Mexicano | 64 | |
| Antonio Sada | Axtel SAB de | N/A | |
| Carlos Guillermo | Axtel SAB de | 57 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0682 |
Mdica Sur SAB Leadership Team
Elected by the shareholders, the Mdica Sur's board of directors comprises two types of representatives: Mdica Sur inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mdica. The board's role is to monitor Mdica Sur's management team and ensure that shareholders' interests are well served. Mdica Sur's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mdica Sur's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jose Rovelo, Director of Surgery, Director | ||
| Engineer Nieves, Director HR | ||
| Martha Ostos, Ex Imaging | ||
| Jorge Reyna, Director of Systems and Information Technology | ||
| Concepcion Ruiloba, Director of Marketing, Communication and Special Events | ||
| Jos Ortiz, Chief Officer | ||
| Francisco Jimenez, Independent Director | ||
| Santiago Borde, Independent Director | ||
| Fernando Navarro, Director | ||
| Juan Hernando, Chief Executive Officer, Director | ||
| Daniel Loaisa, Independent Director | ||
| Omar Garcia, Director of Human Resources | ||
| Xavier Mainero, Independent Director | ||
| Luis Morales, Independent Director | ||
| Ruben Cruz, Director of Internal Audit | ||
| Jorge Martinez, Director of Sales | ||
| Juan Ramirez, Independent Director | ||
| Manuel Madrid, Independent Director | ||
| Jaime Gracia, Alliances Strategy | ||
| Eduardo Pier, Independent Director | ||
| Misael Esquivel, Chairman of the Board, Executive President | ||
| Mario Benard, Director | ||
| L Hernando, MD Director | ||
| Santiago Servitje, Director, Laboratory Director | ||
| Alejandro Pradrazzi, Independent Director | ||
| Joaquin Guajardo, Independent Director | ||
| Cuauhtemoc Otero, Interim Legal Director, Secretary | ||
| Marisol Mollon, Chief Financial and Administrative Officer | ||
| Santiago Perez, Independent Director | ||
| Octavio Chon, Medical General Director, Director and Member of Corporate Practice Committee | ||
| Xochitl Castaneda, Independent Director | ||
| Genaro Estrada, Director | ||
| Enrique Mejorada, Independent Director |
Mdica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mdica Sur a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0682 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.62 B | |||
| Shares Outstanding | 123.28 M | |||
| Shares Owned By Insiders | 50.00 % | |||
| Shares Owned By Institutions | 4.21 % | |||
| Price To Earning | 6.81 X | |||
| Price To Book | 0.82 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Mdica Stock
Mdica Sur financial ratios help investors to determine whether Mdica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mdica with respect to the benefits of owning Mdica Sur security.